2026-02-20, 2:08:21 p.m.
MALVERN, Pa. — February 20, 2026 — Leads & Copy —
TELA Bio, Inc. (NASDAQ: TELA) has announced the approval of inducement grants of restricted stock units covering 8,550 shares of its common stock to three newly-hired employees.
The grants were approved by the Compensation Committee of the Board of Directors of TELA Bio, a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions. The grant date was February 18, 2026.
The restricted stock units were granted pursuant to the Nasdaq Rule 5635(c)(4) inducement grant exception as a component of each individual’s employment compensation. They were granted as an inducement material to each individual’s acceptance of employment with TELA Bio.
The restricted stock units will vest in equal annual installments over four years, subject to each individual’s continued service with TELA Bio through the applicable vesting dates.
TELA Bio, Inc. (NASDAQ: TELA) is focused on providing technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy. The Company is committed to providing surgeons with soft-tissue reconstruction solutions that leverage the patient’s natural healing response while minimizing long-term exposure to permanent synthetic materials.
Source: TELA Bio
